Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation

[1]  S. Chevret,et al.  Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. , 2003, Blood.

[2]  S. Asano,et al.  Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan , 2003, British journal of haematology.

[3]  M. Salavert,et al.  Early infections in adult patients undergoing unrelated donor cord blood transplantation , 2002, Bone Marrow Transplantation.

[4]  M. Boeckh,et al.  Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. , 1999, Blood.

[5]  M. Boeckh,et al.  Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome. , 1997, Blood.

[6]  H. Rollag,et al.  Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. , 1996, Blood.

[7]  C. Crumpacker.  Drug therapy : Ganciclovir , 1996 .

[8]  S. Forman,et al.  Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? [see comments] , 1994 .

[9]  S. Forman,et al.  Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? , 1994, Blood.

[10]  G. Schoch,et al.  Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.

[11]  R. Bevan,et al.  Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function. , 1988, Reviews of infectious diseases.

[12]  D. Snydman.  Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. , 1988, Reviews of infectious diseases.

[13]  J. Sommadossi,et al.  Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro , 1987, Antimicrobial Agents and Chemotherapy.